Aldeyra Therapeutics (ALDX) Preferred Dividend Payments (2013 - 2014)

Aldeyra Therapeutics (ALDX) posted Preferred Dividend Payments of -$3.7 million for Q4 2014, down 1842.12% on a QoQ basis from -$191568.0 in Q3 2014, and down 1134.89% year-over-year from $359504.0 in Q4 2013.

Aldeyra Therapeutics (ALDX) Preferred Dividend Payments (2013 - 2014) Analysis & Trends

Aldeyra Therapeutics' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at -$3.7 million for Q4 2014.

  • Quarterly Preferred Dividend Payments fell 1134.89% year-over-year to -$3.7 million in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $333082.0 (down 96.25% YoY) and the FY2014 annual result came in at $333082.0, down 59.51% from the prior year.
  • Preferred Dividend Payments was -$3.7 million for Q4 2014 at Aldeyra Therapeutics, down from -$191568.0 in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $8.2 million in Q3 2013 and bottomed at -$3.7 million in Q4 2014.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Oculis Holding AG 66,921.77 Bn 66,921.49 Bn - -
2 Nanobiotix 1,933.35 Bn 1,933.29 Bn - -
3 Akari Therapeutics 1,063.56 Bn 1,063.56 Bn - -
4 BeOne Medicines 468.54 Bn 463.75 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 123.45 Bn 116.20 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 70.42 Bn 61.67 Bn 3.31 Bn -
7 Belite Bio 63.57 Bn 63.57 Bn - -
8 Argenx Se 55.83 Bn 50.65 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.75 Bn 34.74 Bn 959.66 Mn -
10 Aldeyra Therapeutics 94.70 Mn 94.70 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2014 -3.72 Mn
Sep 30, 2014 -191,568.00
Jun 30, 2014 4.05 Mn
Mar 31, 2014 191,568.00
Dec 31, 2013 359,504.00
Sep 30, 2013 8.24 Mn
Jun 30, 2013 150,095.00
Mar 31, 2013 123,159.00